PMC:7029449 / 8066-8651 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"134","span":{"begin":250,"end":259},"obj":"Species"},{"id":"135","span":{"begin":284,"end":292},"obj":"Species"},{"id":"136","span":{"begin":56,"end":75},"obj":"Disease"},{"id":"137","span":{"begin":460,"end":469},"obj":"Disease"}],"attributes":[{"id":"A134","pred":"tao:has_database_id","subj":"134","obj":"Tax:2697049"},{"id":"A135","pred":"tao:has_database_id","subj":"135","obj":"Tax:1335626"},{"id":"A136","pred":"tao:has_database_id","subj":"136","obj":"MESH:C000657245"},{"id":"A137","pred":"tao:has_database_id","subj":"137","obj":"MESH:D007239"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Another question on susceptibility is regarding whether 2019-nCoV infection confers neutralising immunity, usually but not always, indicated by the presence of neutralising antibodies in convalescent sera. Some experts already questioned whether the 2019-nCoV may behave similarly to MERS-CoV in cases exhibiting mild symptoms without eliciting neutralising antibodies [17]. A separate question pertains to the possibility of antibody-dependent enhancement of infection or of disease [18,19]. If either of these were to be relevant, the transmission dynamics could become more complex."}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T57","span":{"begin":56,"end":65},"obj":"SP_7"},{"id":"T56","span":{"begin":173,"end":183},"obj":"GO:0042571"},{"id":"T55","span":{"begin":250,"end":259},"obj":"SP_7"},{"id":"T54","span":{"begin":284,"end":292},"obj":"SP_9"},{"id":"T53","span":{"begin":358,"end":368},"obj":"GO:0042571"},{"id":"T52","span":{"begin":426,"end":434},"obj":"GO:0042571"}],"text":"Another question on susceptibility is regarding whether 2019-nCoV infection confers neutralising immunity, usually but not always, indicated by the presence of neutralising antibodies in convalescent sera. Some experts already questioned whether the 2019-nCoV may behave similarly to MERS-CoV in cases exhibiting mild symptoms without eliciting neutralising antibodies [17]. A separate question pertains to the possibility of antibody-dependent enhancement of infection or of disease [18,19]. If either of these were to be relevant, the transmission dynamics could become more complex."}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T4","span":{"begin":426,"end":434},"obj":"Body_part"}],"attributes":[{"id":"A4","pred":"fma_id","subj":"T4","obj":"http://purl.org/sig/ont/fma/fma62871"}],"text":"Another question on susceptibility is regarding whether 2019-nCoV infection confers neutralising immunity, usually but not always, indicated by the presence of neutralising antibodies in convalescent sera. Some experts already questioned whether the 2019-nCoV may behave similarly to MERS-CoV in cases exhibiting mild symptoms without eliciting neutralising antibodies [17]. A separate question pertains to the possibility of antibody-dependent enhancement of infection or of disease [18,19]. If either of these were to be relevant, the transmission dynamics could become more complex."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T39","span":{"begin":56,"end":75},"obj":"Disease"},{"id":"T40","span":{"begin":66,"end":75},"obj":"Disease"},{"id":"T41","span":{"begin":460,"end":469},"obj":"Disease"}],"attributes":[{"id":"A39","pred":"mondo_id","subj":"T39","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A40","pred":"mondo_id","subj":"T40","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"id":"A41","pred":"mondo_id","subj":"T41","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"}],"text":"Another question on susceptibility is regarding whether 2019-nCoV infection confers neutralising immunity, usually but not always, indicated by the presence of neutralising antibodies in convalescent sera. Some experts already questioned whether the 2019-nCoV may behave similarly to MERS-CoV in cases exhibiting mild symptoms without eliciting neutralising antibodies [17]. A separate question pertains to the possibility of antibody-dependent enhancement of infection or of disease [18,19]. If either of these were to be relevant, the transmission dynamics could become more complex."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T40","span":{"begin":375,"end":376},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"Another question on susceptibility is regarding whether 2019-nCoV infection confers neutralising immunity, usually but not always, indicated by the presence of neutralising antibodies in convalescent sera. Some experts already questioned whether the 2019-nCoV may behave similarly to MERS-CoV in cases exhibiting mild symptoms without eliciting neutralising antibodies [17]. A separate question pertains to the possibility of antibody-dependent enhancement of infection or of disease [18,19]. If either of these were to be relevant, the transmission dynamics could become more complex."}

{"project":"LitCovid-sentences","denotations":[{"id":"T45","span":{"begin":0,"end":205},"obj":"Sentence"},{"id":"T46","span":{"begin":206,"end":374},"obj":"Sentence"},{"id":"T47","span":{"begin":375,"end":492},"obj":"Sentence"},{"id":"T48","span":{"begin":493,"end":585},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Another question on susceptibility is regarding whether 2019-nCoV infection confers neutralising immunity, usually but not always, indicated by the presence of neutralising antibodies in convalescent sera. Some experts already questioned whether the 2019-nCoV may behave similarly to MERS-CoV in cases exhibiting mild symptoms without eliciting neutralising antibodies [17]. A separate question pertains to the possibility of antibody-dependent enhancement of infection or of disease [18,19]. If either of these were to be relevant, the transmission dynamics could become more complex."}